Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,827 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00060944 | A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | completed | Phase 2 | 271 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 8 | Sep 8, 2014 | clinicaltrials |
| NCT00132379 | ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 1 | 13 | Active Biotech ABINDUSTRY | 3 | Aug 27, 2014 |
| clinicaltrials |
| NCT00374322 | Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | completed | Phase 3 | 3,166 | GlaxoSmithKlineINDUSTRY | 33 | Aug 18, 2014 | clinicaltrials |
| NCT00125034 | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)(OPUS) | completed | Phase 2 | 344 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 13 | Aug 7, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT01519648 | A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation | completed | — | 808 | National Hematological Society, RussiaOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00373204 | Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | terminated | Phase 2 | 50 | Pharmacyclics LLC.INDUSTRY | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | completed | Phase 3 | 442 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 17 | Jul 23, 2014 | clinicaltrials |
| NCT00356811 | Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer | completed | Phase 2 | 57 | GlaxoSmithKlineINDUSTRY | 4 | Jul 21, 2014 | clinicaltrials |
| NCT00678535 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer(EXPAND) | completed | Phase 3 | 904 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 25 | Jul 21, 2014 | clinicaltrials |
| NCT00424255 | Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery | completed | Phase 3 | 688 | GlaxoSmithKlineINDUSTRY | 22 | Jul 18, 2014 | clinicaltrials |
| NCT00165880 | An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine | terminated | Phase 2 | 62 | Eisai LimitedINDUSTRY | 5 | Jul 1, 2014 | clinicaltrials |
| NCT00113607 | An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer | completed | Phase 3 | 672 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 20 | Jun 27, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT01208194 | Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma(IMPACT) | completed | Phase 2 | 59 | Mologen AGINDUSTRY | 6 | Jun 20, 2014 | clinicaltrials |
| NCT00507429 | Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer(FACT) | terminated | Phase 2 / Phase 3 | 80 | Mateon TherapeuticsINDUSTRY | 12 | Jun 9, 2014 | clinicaltrials |
| NCT00378690 | A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD(ICELAND) | completed | Phase 3 | 706 | Astellas Pharma IncINDUSTRY | 10 | Jun 4, 2014 | clinicaltrials |
| NCT00946920 | A Trial of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 859 | Ferring PharmaceuticalsINDUSTRY | 14 | Jun 2, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer(IES) | completed | Phase 3 | 4,740 | PfizerINDUSTRY | 37 | May 7, 2014 | clinicaltrials |
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | completed | Phase 3 | 751 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 18 | Apr 21, 2014 | clinicaltrials |
| NCT00364754 | Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer | completed | Phase 1 | 28 | YM BioSciencesINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00786838 | A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | completed | Phase 2 | 76 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 7 | Apr 11, 2014 | clinicaltrials |
| NCT01587430 | 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia | unknown | Phase 4 | 245 | National Research Center for Hematology, RussiaNETWORK | 1 | Apr 7, 2014 | clinicaltrials |
| NCT01345214 | A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 17 | Ono Pharma USA IncINDUSTRY | 3 | Apr 1, 2014 | clinicaltrials |
| NCT00112060 | A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 / Phase 2 | 0 | Spectrum Pharmaceuticals, IncINDUSTRY | 2 | Mar 31, 2014 | clinicaltrials |
| NCT00751036 | Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg(MACS0375) | terminated | Phase 3 | 94 | Novartis PharmaceuticalsINDUSTRY | 9 | Mar 26, 2014 | clinicaltrials |
| NCT01429051 | A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain(NOSE-400) | completed | Phase 3 | 46 | TakedaINDUSTRY | 3 | Mar 26, 2014 | clinicaltrials |
| NCT01543451 | Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea | completed | Phase 2 | 138 | Helsinn Healthcare SAINDUSTRY | 4 | Mar 26, 2014 | clinicaltrials |
| NCT00441168 | Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma | terminated | Phase 2 | 30 | Janssen-Cilag International NVINDUSTRY | 7 | Mar 21, 2014 | clinicaltrials |
| NCT00086580 | Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients | completed | Phase 3 | 335 | Genzyme, a Sanofi CompanyINDUSTRY | 15 | Mar 13, 2014 | clinicaltrials |
| NCT00891475 | Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients | completed | Phase 1 / Phase 2 | 114 | Kidney Cancer Research BureauOTHER | 1 | Feb 13, 2014 | clinicaltrials |
| NCT00073307 | Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer | completed | Phase 3 | 903 | BayerINDUSTRY | 19 | Feb 6, 2014 | clinicaltrials |
| NCT02056587 | Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment | completed | Phase 4 | 37 | Kidney Cancer Research BureauOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00499239 | A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) | terminated | Phase 1 / Phase 2 | 32 | Gilead SciencesINDUSTRY | 3 | Feb 4, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00030641 | Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | Genta IncorporatedINDUSTRY | 3 | Jan 6, 2014 | clinicaltrials |
| NCT00312208 | Docetaxel in Breast Cancer | completed | Phase 3 | 3,299 | SanofiINDUSTRY | 37 | Dec 30, 2013 | clinicaltrials |
| NCT00004218 | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | completed | Phase 3 | — | Leukemia Research FundOTHER | 8 | Dec 18, 2013 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT01310816 | A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma | completed | Phase 2 | 105 | Infinity Pharmaceuticals, Inc.INDUSTRY | 13 | Dec 5, 2013 | clinicaltrials |
| NCT01561456 | Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | completed | Phase 2 | 100 | Axelar ABINDUSTRY | 5 | Dec 5, 2013 | clinicaltrials |
| NCT00431561 | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma | completed | Phase 2 | 141 | Isarna Therapeutics GmbHINDUSTRY | 6 | Dec 3, 2013 | clinicaltrials |
| NCT00320190 | Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib | terminated | Phase 2 | 52 | Bristol-Myers SquibbINDUSTRY | 11 | Oct 30, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials